Artivion | CRY - Debt


Artivion reported $317.78M in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.05M 736K Jun/2026
Baxter International USD 9.67B 20M Jun/2026
Becton, Dickinson and Co. USD 16.81B 471M Jun/2026
Boston Scientific USD 12.62B 1.6B Jun/2026
Edwards Lifesciences USD 598.8M 105.6M Sep/2026
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 2.05B 9.43M Jun/2026
J&J USD 49.04B 5.95B Jun/2026
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Pfizer USD 62.67B 523M Sep/2026
ResMed USD 825.92M 17.25M Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 2.87B 186.84M Jun/2026
Terumo JPY 389.46B 9.67B Jun/2026
Trinity Biotech USD 137.98M 37.22M Dec/2025